Due to defects in workmanship and materials that cause dangerous side effects
Withdrawal of 43 drugs from pharmacies in 2020
Manufacturing companies issued decisions to voluntarily withdraw some of their products.
Archives
Pharmacists in Abu Dhabi informed «Emirates Today» that the number of pharmaceutical batches, which were withdrawn from pharmacies and suspended during the last year 2020, amounted to about 43 pharmaceutical batches and products, for treating diabetes, coughing, acidity, antidepressant, slimming, and treatment of hypercholesterolemia. And antibiotics, after establishing a number of violations against them, including the non-conformity of the content of the active substances to the approved specifications, and the containment of some products on colored dye materials that do not comply with the approved specifications for the specified dyes, and the presence of impurities and foreign particles in the products, in addition to the difference in the drug concentration over time And when storing.
The decisions to withdraw and suspend the registration of a number of medicinal products issued by the health authorities in the country indicated that these operations are manufactured by companies from Arab, European and Asian countries, and that some of these medicines are registered in the country, and some are not registered with the Ministry of Health and Community Protection, and invited the managers Pharmacies should stop dispensing the aforementioned batches and return them to the supplier, and in the event of any side effects resulting from the use of these products, contact with the "Pharmacovigilance" program.
The decision to withdraw some pharmaceutical operations came based on the manufacturers ’decisions to voluntarily withdraw some of their products, after the results of the tests showed that there were defects in manufacturing, or notes on the sterilization of the product after manufacturing, or its expiration date, or it was found that the product did not meet the required specifications, while some were withdrawn. Other operations after discovering that they are counterfeit, as the original manufacturer of the product reported that it did not produce or distribute the products that were withdrawn, while the registration of medicinal products containing the substance «bovexamac» was canceled, based on the receipt of several foreign reports of skin side effects Seriously requiring hospitalization.
Reasons for withdrawal and suspension of sale included the possibility of exposing the users of these batches to heart attacks and strokes, the results of the laboratory analysis showing that the products do not conform to the approved international specifications, the possibility of exposing the consumer to unacceptable levels of these impurities, and finding an undeclared drug substance (paracetamol), and no It is permissible to circulate without registering it with the Ministry of Health and Community Protection, and the presence of white-colored deposits visible to the naked eye in the solution, which is administered intravenously, and the presence of glass particles in the form of chips in the packages, in addition to finding particles of a substance not registered in the product.
Doctors and pharmacists: Muhammad Saeed, Walaa Ahmed, Ola Abdullah, Muhammad Shahdi, and Yasser Muhammad explained that the drugs in suspension are used for treating allergies and bronchial irritation, acidity and for treating esophageal reflux, antibacterial for treating otolaryngitis, and antibacterial for treating respiratory infection, And reduce the production of cholesterol in the liver, and third-degree colon cancer, and bowel and rectal cancer in its advanced stages, in addition to back and spine pain.
Standard barcode
Pharmacists have confirmed that the standard barcode system "GS1" has been approved and applied in the Emirate of Abu Dhabi, on all pharmaceutical products registered with the Ministry of Health and Community Protection, and included in the list of approved drugs, so that every package of a drug product must contain a unique "two-dimensional" QR code. It should contain product identification information, including the international commercial product “GTIN” number for the drug product, the drug's expiration date, the batch number, and the serial number for each package separately. They indicated that drug companies and manufacturers are obligated to subscribe to the UAE GS1 platform, and upload information Related products, and the completion of the application of the GS1 barcode on all pharmaceutical product packages, by the first of next July, and after this date, the sale and distribution of products that do not contain the standard GS1 barcode will not be allowed in the Emirate of Abu Dhabi.
Medicines suspended circulating, are used to treat allergies and bronchial irritation.
The withdrawal of some pharmaceutical batches was based on the manufacturers ’decisions.
Follow our latest local and sports news, and the latest political and economic developments via Google news